Skandinaviska Enskilda Banken (SEB)’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,267
Closed -$413K 812
2024
Q1
$413K Sell
1,267
-1,100
-46% -$270K ﹤0.01% 713
2023
Q4
$451K Buy
2,367
+67
+3% +$12.7K ﹤0.01% 783
2023
Q3
$458K Sell
2,300
-500
-18% -$118K ﹤0.01% 776
2023
Q2
$799K Sell
2,800
-2,800
-50% -$778K 0.01% 730
2023
Q1
$1.21M Hold
5,600
0.01% 664
2022
Q4
$1.15M Buy
+5,600
New +$1.42M 0.01% 648

Other funds holding SWAV

Skandinaviska Enskilda Banken (SEB)'s SWAV Position: Q2 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,267 shares — an estimated $413K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in SWAV in Q4 2022 and held it in 6 quarters. The position peaked at $1.21M in Q1 2023. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 1,267 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $413K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Shockwave Medical, Inc. Common Stock position peaked at $1.21M in Q1 2023.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2024, filed 13 Aug 2024.